In the second cohort of patients, the highest AM PD-L1 expression levels were detected in patients with GOLD 1–2 COPD and patients with NSCLC, whom both had very similar levels of AM PD-L1 expression. The gene discussed is CD274; the disease is non-small cell lung carcinoma.